PrairieView Partners’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$2K Hold
25
﹤0.01% 347
2025
Q1
$2K Sell
25
-43
-63% -$4.6K ﹤0.01% 337
2024
Q4
$7K Hold
68
﹤0.01% 307
2024
Q3
$7K Hold
68
﹤0.01% 299
2024
Q2
$7K Sell
68
-5
-7% -$589 ﹤0.01% 314
2024
Q1
$10K Hold
73
﹤0.01% 285
2023
Q4
$9K Hold
73
﹤0.01% 282
2023
Q3
$8K Hold
73
﹤0.01% 300
2023
Q2
$10K Hold
73
﹤0.01% 323
2023
Q1
$9K Hold
73
﹤0.01% 316
2022
Q4
$9K Hold
73
﹤0.01% 329
2022
Q3
$8K Hold
73
﹤0.01% 324
2022
Q2
$8K Hold
73
﹤0.01% 346
2022
Q1
$9K Sell
73
-2
-3% -$241 ﹤0.01% 338
2021
Q4
$9K Hold
75
﹤0.01% 324
2021
Q3
$11K Hold
75
﹤0.01% 269
2021
Q2
$12K Hold
75
﹤0.01% 262
2021
Q1
$12K Hold
75
﹤0.01% 261
2020
Q4
$11K Hold
75
﹤0.01% 244
2020
Q3
$10K Hold
75
﹤0.01% 241
2020
Q2
$9K Hold
75
﹤0.01% 239
2020
Q1
$7K Buy
+75
New +$9.83K ﹤0.01% 242

Other funds holding ZBH

PrairieView Partners's ZBH Position: Q2 2025 in Review

PrairieView Partners held its Zimmer Biomet (ZBH) position steady in Q2 2025 at 25 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #347.

PrairieView Partners first reported a position in ZBH in Q1 2020 and has held it in 22 quarters since. The position peaked at $12K in Q2 2021. 934 funds tracked by Wall St. Rank hold ZBH as of Q2 2025.

  • PrairieView Partners held 25 shares of Zimmer Biomet worth $2K as of Q2 2025.
  • PrairieView Partners left its Zimmer Biomet share count unchanged in Q2 2025.
  • Zimmer Biomet made up ﹤0.01% of PrairieView Partners's portfolio in Q2 2025, its #347 holding.
  • PrairieView Partners first reported a position in Zimmer Biomet in Q1 2020 and has held it in 22 quarters since.
  • PrairieView Partners's Zimmer Biomet position peaked at $12K in Q2 2021.
  • 934 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2025.

Based on PrairieView Partners's 13F filing for Q2 2025, filed 25 Jul 2025.